BNET Industries

Market Cap:$2.0B
Last Fiscal Year Sales:$2.8B
- Public
- US
Dow Jones Description
Carlisle is a diversified global manufacturing company serving the construction materials, commercial roofing, specialty tire and wheel, power transmission, heavy-duty brake and friction, heavy-haul truck trailer, refrigerated truck body, foodservice, and aerospace, and test and measurement industries.
President & Chief Executive Officer
David A. RobertsNumber of Employees 11,000
Contact Information
13925 Ballantyne Corporate Pl Ste 400
Charlotte, North Carolina 28277
(704) 501-1100
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Carlisle Companies CSL Declare $0.16 Quarterly Dividend; 2% Yield
-
Carlisle Company Inc names Robin J. Adams to board
-
Carlisle Companies Sales Decline 27% in 3Q
-
Carlisle Acquires Electronic Cable Specialists
-
Carlisle acquires Jerrik for undisclosed price
-
Carlisle Announces 33rd Consecutive Year of Dividend Increases
-
Carlisle Companies 2Q Sales Fall 28%
-
Carlisle Companies Will Announce 2nd Quarter 2009 Earnings on
News & Analysis
Filter by
csl ltd. - All News and Analysis
DSM and Crucell Announce PER.C6(R) License Agreement with CSL Ltd.
Leiden, The Netherlands/Parsippany, USA, 18 December 2008 - DSM Biologics, a business unit of DSM Pharmaceutical Products, and Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX), today announced that CSL Limited, a global...
CSL Marks 40 Years in the Influenza Vaccine Market
A Leading Provider of Vaccine in the Southern Hemisphere and Europe PARKVILLE, Australia -- CSL Limited today celebrated its 40th year as a leading manufacturer of the influenza flu vaccine. The company's vaccine, Fluvax([R]), is a Thiomersal-free influenza vaccine that is approved for use in adults and children in...
GateKeeper USA, Inc. Announced Today It Has Executed an Exclusive Development & License Agreement with Container Security Logistics, LLC
GAITHERSBURG, Md. -- GateKeeper USA, Inc. (Pink Sheets: GTKP, formerly GKPR), announced today that it has executed an Exclusive Development & Licensing Agreement with Container Security Logistics, LLC ("CSL"). GateKeeper USA Inc. had issued a "Request for Proposal" RFP for technology that is non RFID dependant, not "Current Off...
Australian flu-vaccine firm talks with FDA
An Australian company with U.S. operations in King of Prussia is in talks with the Food and Drug Administration to sell as many as 20 million doses of its seasonal influenza vaccine in the United States. Australia's CSL Ltd. and its King of Prussia subsidiary ZLB Behring, a blood-products...
CSL Limited to Apply for License to Market Influenza Vaccine in the U.S.; Major Vaccine Manufacturer to Double Capacity
NEW YORK -- CSL Limited (ASX: CSL), a global, specialty biopharmaceutical company headquartered in Melbourne, Australia, today announced plans to introduce its influenza vaccine into the U.S. market. Speaking at Merrill Lynch's Global Pharmaceutical and Biotechnology Conference here, CSL Chief Executive Officer and Managing Director Dr. Brian McNamee said,...
Managing change and integration at ZLB Behring
Realizing the desired goals of a merger and acquisition is notoriously difficult. Which is why parent company CSL Limited had a communication team ready and waiting when it announced the merger between acquired company Aventis Behring and ZLB Bioplasma. Here, Ros Williamson describes how careful planning, due diligence and a...
SHARES IN AUSTRALIA'S CSL HIT THREE YEAR LOWS ON U.S. CONCERNS.
MELBOURNE, Feb 10 Asia Pulse - Shares in blood products firm CSL Ltd (ASX:CSL) fell to their lowest close in more than three years today on continued concerns over the company's position in its key United States market. CSL shares dropped 64 cents, or four per cent, to...
INVESTORS WIPE US$78.24 MLN OFF VALUE OF AUSTRALIA'S CSL LTD.
BRISBANE, Nov 11 Asia Pulse - Investors today wiped A$139 million (US$78.24 million) off the value of blood and plasma outfit CSL Ltd (ASX:CSL), amid fears rival global heavyweights could move in on the Australian market. Today's latest rout saw CSL shares shed 88 cents or 5.03 per...
Blood pressure baffles pundits.
Oct 20, 2002 (The Sunday Mail - Queensland - ABIX via COMTEX) The share price of Australia's CSL Limited fell sharply on 17 October 2002, slashing its market capitalisation by $A382m. The downturn followed a profit warning, with the biotechnology group advising that earnings...
AUSTRALIA'S CSL SHARES PLUNGE WITH EARNINGS WARNING.
MELBOURNE, Oct 17 Asia Pulse - Shares in blood products group CSL Ltd (ASX:CSL) fell more than 11 per cent today as the company warned foreign exchange movements could reduce earnings by $A15 ($US8.21)-$A20 million ($US10.95 million). CSL also said weakness in prices for its IVIG intravenous immunoglobulin...
Decision Makers
| Name (plus bio) | Position |
|---|---|
| David A. Roberts | President & Chief Executive Officer |
| Fred A. Sutter | Group President, Transportation Prod |
| Kevin G. Forster | Group President, Specialty Prod |
| Carol Lowe | Vice President & Chief Financial Officer |
| Scott C Selbach | Vice President, Corp Dev |
| Steven Ford | General Counsel, Secretary & Vice President |
| Philip C. Aldinger | Controller |
| Kirk Vincent | Corporate Counsel |
| Anthony W. Ruggiero | Director |
| Lawrence A. Sala | Director |
| Magalen C. Webert | Director |
| Peter F. Krogh | Director |
| Peter L.A. Jamieson | Director |
| Donald G. Calder | Member of Corporate Governance and Nominating Committee |
| Eriberto R. Scocimara | Member of Compensation Committee |
| Stephen P. Munn | Member of Executive Committee |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Gregg A. Ostrander | Board of Directors |
| Magalen Bryant | Board of Directors |
| Paul J. Choquette | Board of Directors |
| Robert G. Bohn | Board of Directors |
| Robin S. Callahan | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | President & Chief Executive Officer | Current |
| Carlisle Companies Incorporated | Chairman | Current |
| ADC Telecommunications, Inc. | Board of Directors | Current |
| Franklin Electric Co., Inc. | Director | Current |
| Franklin Electric Co., Inc. | Chairman of The Board, President and Chief Executive Officer, Carlisle Companies, Inc. (B, C) | Former |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Group President, Transportation Prod | Current |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Group President, Specialty Prod | Current |
| Carlisle Companies Incorporated | Director, Corp Development | Former |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Vice President & Chief Financial Officer | Current |
| Carlisle Companies Incorporated | Treasurer | Former |
Prior to joining Torridon, Mr. Selbach was employed by Carlisle Companies Inc. for 12 years, first as Vice President & General Counsel, then as Vice President, Europe (residing in London, England) and most recently as Vice President - Corporate Development, where he managed acquisition, joint venture and divestiture activities for the company involving more than 30 domestic and global transactions over the last four years. Mr. Selbach has extensive experience in planning, structuring, negotiating and completing all types of buy/sell business transactions. Prior to Carlisle, Mr. Selbach was an attorney with the Syracuse law firm of Bond, Schoeneck & King, where he was involved in tax planning and business transactional work for five years.
| Organization | Position | Status |
|---|---|---|
| Torridon Companies | Vice President | Current |
| Carlisle Companies Incorporated | Vice President, Corp Dev | Current |
| Torridon Companies | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | General Counsel, Secretary & Vice President | Current |
| Carlisle Companies Incorporated | Secretary | Current |
| Carlisle Companies Incorporated | General Counsel | Former |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Controller | Current |
| Organization | Position | Status |
|---|---|---|
| Vetco Aibel Kazakhstan Llp | Executive Vice President and Cfo | Current |
| Carlisle Companies Incorporated | Corporate Counsel | Current |
| Carlisle Companies Incorporated | Vice President and Chief Financial Officer | Former |
| Vetco International Limited | Cfo & Executive Vice President | Former |
| Dickinson School of Law | Jd | Former |
| University of Virginia | BA In Philosophy | Former |
| Organization | Position | Status |
|---|---|---|
| Olin Corporation | Director | Current |
| Carlisle Companies Incorporated | Director | Current |
| Carlisle Companies Incorporated | Member of Pension and Benefits Committee | Current |
| Olin Corporation | Chief Financial Officer | Former |
| Olin Corporation | Executive Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| Arctic Cat Inc. | Executive Chairman, Michael Foods Inc. Minneapolis, Mn | Current |
| Michael Foods, Inc. | Chairman | Current |
| Arctic Cat Inc. | Board of Directors | Current |
| Carlisle Companies Incorporated | Board of Directors | Current |
| Birds Eye Foods, Inc. | Board of Directors | Current |
| Michael Foods, Inc. | Chief Executive Officer | Former |
| Michael Foods, Inc. | President | Former |
| Michael Foods, Inc. | Coo | Former |
Lawrence A. Sala joined the Company in 1984. He has been President since May 1995, has served as Chief Executive Officer since September 1997, and has been Chairman of the Board of Directors since November 2001. Mr. Sala became a member of the Board of Directors of the Company in 1995. He holds a Bachelor's Degree in Computer Engineering, a Master's Degree in Electrical Engineering and a Master's Degree in Business Administration, all from Syracuse University. Mr. Sala is also a member of the Boards of Directors of Carlisle Companies, Incorporated and Syracuse Research Corporation.
| Organization | Position | Status |
|---|---|---|
| Anaren, Inc. | Chief Executive Officer | Current |
| Anaren, Inc. | President | Current |
| Anaren, Inc. | Chairman | Current |
| Syracuse Research Corporation | Board of Directors | Current |
| Carlisle Companies Incorporated | Director | Current |
| Carlisle Companies Incorporated | Member of Audit Committee | Current |
| Syracuse Research Corporation | President & CEO, Anaren | Former |
| Organization | Position | Status |
|---|---|---|
| The Wild Foundation | Board of Directors | Current |
| Carlisle Companies Incorporated | Board of Directors | Current |
| Dover Corporation | Board of Directors | Current |
| National Fish and Wildlife Foundation | Chairperson | Former |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Director | Current |
| Carlisle Companies Incorporated | Member of Corporate Governance and Nominating Committee | Current |
| Organization | Position | Status |
|---|---|---|
| New England Futures | Current | |
| Gilbane Development Company | Chairman | Current |
| Gilbane, Inc. | Chairman | Current |
| Chilmark Technology Group | Chairman | Current |
| Carlisle Companies Incorporated | Board of Directors | Current |
| Carlisle Companies Incorporated | Member of Corporate Governance and Nominating Committee | Current |
| Gilbane, Inc. | Chief Executive Officer | Former |
| Gilbane Building Company | Chief Legal Counsel | Former |
| Chilmark Technology Group | Chief Legal Counsel | Former |
| Gilbane, Inc. | Chief Legal Counsel | Former |
| Gilbane Development Company | Chief Legal Counsel | Former |
| Brown University | Graduate | Former |
| Harvard Law School | Ll.B. Degree | Former |
| Harvard Law School | Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Georgetown University | Dean Emeritus | Current |
| Carlisle Companies Incorporated | Director | Current |
| Carlisle Companies Incorporated | Member of Corporate Governance and Nominating Committee | Current |
| Organization | Position | Status |
|---|---|---|
| Jardine Strategic Holdings, Ltd. | Director | Current |
| Carlisle Companies Incorporated | Director | Current |
| Carlisle Companies Incorporated | Member of Pension and Benefits Committee | Current |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Board of Directors | Current |
Donald G. Calder is President of G. L. Ohrstrom & Co., Inc. and has been associated with the firm since 1965. He has been actively involved in the origination of numerous Ohrstrom-sponsored acquisitions and has worked closely with the senior management teams of these investments. He is a graduate of Princeton University (AB) and The Harvard Business School (MBA). He served in the U.S. Navy and worked on Wall Street. He is a member of the Board of Directors of Carlisle Companies Incorporated, Roper Industries, Inc., Brown-Forman Corporation, and Central Securities. He is Chairman of the Board of Tritex Holdings, V.I.P. Incorporated and President of Vistan Corporation. He is a Trustee of the National Sporting Library and the American Skin Association.
| Organization | Position | Status |
|---|---|---|
| G.L. Ohrstrom & Co., Inc | President | Current |
| Roper Industries, Inc. | Board of Directors | Current |
| Brown-Forman Corporation | Director | Current |
| National Sporting Library | Board of Directors | Current |
| Central Securities Corp. | Board of Directors | Current |
| G.L. Ohrstrom & Co., Inc | Board Director | Current |
| American Skin Association | Board of Directors | Current |
| Brown-Forman Corporation | Nominating Committee Member | Current |
| Carlisle Companies Incorporated | Member of Corporate Governance and Nominating Committee | Current |
| G.L. Ohrstrom & Co., Inc | Chief Financial Officer | Former |
| Roper Industries, Inc. | Vice President | Former |
| G.L. Ohrstrom & Co., Inc | Partner | Former |
| Central Securities Corp. | Chairman | Former |
| Harvard Business School | Mba | Former |
| Princeton University | Ab | Former |
Eriberto R. Scocimara joined the board of directors of American Reprographics Company in May 2006. Mr. Scocimara has served as the President and Chief Executive Officer of the Hungarian-American Enterprise Fund, a privately managed investment company created by the President and Congress of the United States and funded by the U.S. Government, since 1994. He also has served as the President and Chief Executive Officer of Scocimara & Company, Inc., a financial consulting firm, since he founded the company in 1984.
| Organization | Position | Status |
|---|---|---|
| American Reprographics Company | Director of American Reprographics Company | Current |
| American Reprographics Company | Board of Directors | Current |
| Victor Innovative Textiles | Board of Directors | Current |
| Roper Industries, Inc. | Board of Directors | Current |
| Euronet Services | Director | Current |
| Carlisle Companies Incorporated | Member of Compensation Committee | Current |
| Organization | Position | Status |
|---|---|---|
| Carlisle Companies Incorporated | Member of Executive Committee | Current |
| Carlisle Companies Incorporated | Chief Executive Officer | Former |
| Carlisle Companies Incorporated | Chairman | Former |
| Carlisle Companies Incorporated | Board of Directors | Former |
Executive News
-
Michael Foods Q2 Earnings Call Transcript
-
Anaren optimistic about new prospects
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- The 10 Weirdest Drug Stories of the Month 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes


